| mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |